Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, View ORCID ProfileJacques Turgeon
doi: https://doi.org/10.1101/2020.04.21.20066761
Veronique Michaud
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Chief Operating Officer
Pamela Dow
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
MSRoles: Clinical Research Manager
Sweilem B. Al Rihani
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
PharmD, PhDRoles: Clinical Research Scientist
Malavika Deodhar
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Clinical Research Scientist
Meghan Arwood
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
PharmDRoles: Clinical Research Scientist
Brian Cicali
2University of Florida Center for Pharmacometrics and Systems Pharmacology, 6550 Sanger Road, Orlando, FL 32827
MScRoles: PhD Student, Pharmaceutics
Jacques Turgeon
1Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, 13485 Veteran’s Way, Suite 410, Orlando, Florida, 32827, USA
BPharm, PhDRoles: Chief Scientific Officer
Posted April 29, 2020.
Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon
medRxiv 2020.04.21.20066761; doi: https://doi.org/10.1101/2020.04.21.20066761
Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: A systematic review
Veronique Michaud, Pamela Dow, Sweilem B. Al Rihani, Malavika Deodhar, Meghan Arwood, Brian Cicali, Jacques Turgeon
medRxiv 2020.04.21.20066761; doi: https://doi.org/10.1101/2020.04.21.20066761
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2318)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11653)
- Forensic Medicine (10)
- Gastroenterology (688)
- Genetic and Genomic Medicine (3656)
- Geriatric Medicine (344)
- Health Economics (625)
- Health Informatics (2341)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3407)
- Nursing (193)
- Nutrition (512)
- Oncology (1788)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (442)
- Pediatrics (1015)
- Primary Care Research (411)
- Public and Global Health (6047)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (392)
- Toxicology (50)
- Transplantation (171)
- Urology (144)